Cite
Using Natriuretic Peptides for Selection of Patients in Acute Heart Failure Clinical Trials.
MLA
Smith, Sakima A., et al. “Using Natriuretic Peptides for Selection of Patients in Acute Heart Failure Clinical Trials.” The American Journal of Cardiology, vol. 116, no. 8, Oct. 2015, pp. 1304–10. EBSCOhost, https://doi.org/10.1016/j.amjcard.2015.07.049.
APA
Smith, S. A., Mentz, R. J., Roessig, L., Mebazza, A., Longrois, D., Gheorghiade, M., Pitt, B., Zannad, F., Butler, J., & Abraham, W. T. (2015). Using Natriuretic Peptides for Selection of Patients in Acute Heart Failure Clinical Trials. The American Journal of Cardiology, 116(8), 1304–1310. https://doi.org/10.1016/j.amjcard.2015.07.049
Chicago
Smith, Sakima A, Robert J Mentz, Lothar Roessig, Alexandre Mebazza, Dan Longrois, Mihai Gheorghiade, Bertram Pitt, Faiez Zannad, Javed Butler, and William T Abraham. 2015. “Using Natriuretic Peptides for Selection of Patients in Acute Heart Failure Clinical Trials.” The American Journal of Cardiology 116 (8): 1304–10. doi:10.1016/j.amjcard.2015.07.049.